Quantcast

Latest Hemodialysis Stories

2014-05-19 08:28:07

LAWRENCE, Mass., May 19, 2014 /PRNewswire/ -- NxStage Medical, Inc. (NASDAQ: NXTM), a leading manufacturer of innovative dialysis products, is proud to share a current NxStage® System One(TM) user's story of courage, persistence and determination. Despite losing both of his kidneys to cancer, Greg, a 65-year-old avid runner, was able to accomplish his goal of running a half marathon this past February in Sacramento. For Greg, more frequent home hemodialysis (HHD) with the NxStage...

2014-05-15 23:08:44

ChinaMarketResearchReports.com adds "Global and China Hemodialysis Industry Report, 2013-2016" market research, on hemodialysis service market and hemodialysis equipment market, to its store. Dallas, TX (PRWEB) May 15, 2014 Global and China Hemodialysis Industry Report, 2013-2016 market research says in 2013, the global number of patients receiving dialysis continued to grow to 2.519 million. The new patients mainly come from Asia Pacific region (excluding Japan). Europe,...

2014-05-14 16:28:26

RIVER EDGE, N.J., May 14, 2014 /PRNewswire/ -- Nephros, Inc. (OTCQB: NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration system for the treatment of chronic renal failure patients, announced today that John C. Houghton, President and Chief Executive Officer, will present at the Third Annual Marcum MicroCap Conference in New York on Thursday, May 29, 2014 at 3:30 p.m. EDT....

2014-05-14 16:28:23

RIVER EDGE, N.J., May 14, 2014 /PRNewswire/ -- Nephros, Inc. (OTCQB: NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration system for the treatment of chronic renal failure patients, announced today financial results for the three months ended March 31, 2014. Recent Highlights -- Commenced shipment of our NanoGuard-D and NanoGuard-S ultrafilters -- Extended and...

2014-05-13 16:28:05

RIVER EDGE, N.J., May 13, 2014 /PRNewswire/ -- Nephros, Inc. (OTCQB: NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration system for the treatment of chronic renal failure patients, announced today the first commercial use of its hemodiafiltration ("HDF") system in the United States. As announced in a separate press release today, DaVita Kidney Care, a division of DaVita...

2014-05-13 08:31:01

Hemodiafiltration Trial Launches in Colorado Springs DENVER, May 13, 2014 /PRNewswire-USNewswire/ -- DaVita Kidney Care, a division of DaVita HealthCare Partners Inc. (NYSE: DVA) and a leading provider of kidney care services, today announced it is now delivering hemodiafiltration treatments to select patients in Colorado Springs as part of a six-month trial program. This marks the first delivery of hemodiafiltration in the United States....

2014-05-09 13:37:38

American Society of Nephrology More frequent face-to-face physician visits in the month following hospital discharge may help reduce a kidney failure patient's chances of needing to be sent back to the hospital. That's the conclusion of a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN). The study also found that closer outpatient monitoring of kidney failure patients following hospital discharge could cut health care costs significantly....

2014-05-06 23:04:50

lifescienceindustryresearch.com adds “U.S. Vascular Device Market 2014” and “2014 Deep Research Report on Global and China Vascular Graft Industry” reports to its research database. Dallas, Texas (PRWEB) May 06, 2014 The report analyzes and evaluates the current state of the market, including existing and potential markets, product average selling prices, and unit volumes. The report also highlights the opportunities and potential hazards involved, and presents strategies for...

2014-05-01 23:14:42

Court Rules All Asserted Patent Claims are Invalid Salt Lake City, UT (PRWEB) May 01, 2014 Catheter Connections, a leading developer of medical devices for the prevention of IV catheter-related bloodstream infections, announced today that the United States District Court for the Southern District of California has ruled that all patent claims asserted by Ivera against Catheter Connections’ DualCap Solo™ are invalid. The Court’s ruling is the final judgment in the case and is in...

2014-04-30 08:31:38

DUNDEE, Scotland, April 30, 2014 /PRNewswire/ -- Forum uniquely brings together leading family offices and their foundations seeking impact investment, grant-giving, and philanthropy opportunities within health and life sciences (Photo: http://photos.prnewswire.com/prnh/20140430/684401 ) Vascular Flow Technologies Ltd, a medical device company focused on the research, development and commercialisation of vascular devices announced today it has been selected to...


Word of the Day
attercop
  • A spider.
  • Figuratively, a peevish, testy, ill-natured person.
'Attercop' comes from the Old English 'atorcoppe,' where 'atter' means 'poison, venom' and‎ 'cop' means 'spider.' 'Coppa' is a derivative of 'cop,' top, summit, round head, or 'copp,' cup, vessel, which refers to 'the supposed venomous properties of spiders,' says the OED. 'Copp' is still found in the word 'cobweb.'
Related